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INTRODUCTION
Dietary modifi cation is the foundation of population strat-
egies for the prevention and treatment of coronary heart dis-
ease (CHD), so it is imperative to identify alternative diets that 
can effectively modify the blood lipid profi le, and thus reduce 
CHD risk. 
Dietary fat is often divided into saturated and unsaturated 
fat. It has been shown that saturated fats increase the risk for 
coronary artery diseases, while unsaturated fatty acid con-
sumption reduces this risk (Demaison et al., 2002). Examples 
through trials based on animal models have strengthen the con-
cept that the decrease in food lipid intake is associated with a 
reduction of the blood cholesterol level as well as with a de-
crease of the risk of CVD (Keys et al., 1996; Nagyova et al., 
2003; Trautwein et al., 1999). 
Scientifi c Advisory of the American Heart Association 
(Kris-Etherton, 1999) reported that high monounsaturated fatty 
acid (MUFA) diets tend to raise HDL and lower triacylglyc-
erol concentration compared with low fat, carbohydrate-rich, 
cholesterol-lowering diets (Grundy, 1986; Mensink and Katan, 
1987). Mesnik et al. (2003) examined the effects of carbohy-
drates and various fats on blood lipid levels. In trials in which 
polyunsaturated and monounsaturated fats were eaten in place 
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Summary
Low-fat diets increase serum triacilglycerol and decrease HDL-cholesterol concentrations, thereby potentially adversely affecting cardio-
vascular disease (CVD) risk. The present study compared the CVD risk profi le of a high-MUFA diets (olive oil) and high-PUFA diets (pumpkin 
seed oil). The most signifi cant difference between the two groups was that the atherogenic index in groups given olive oil was signifi cantly lower 
(for approximately 60 %) than atherogenic index recorded in control group, while in the group receiving pumpkin seed oil this reduction was ap-
proximately 40 %. Collectively, these fi ndings point to the fact that both a high MUFA and PUFA diet may be preferable to a low-fat diet because 
of more favorable effects on the CVD risk profi le.
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Sažetak
Prehrana sa niskim udjelom masti povećav koncentraciju triacilglicerola i snižava koncentraciju HDL-kolesterola u serumu, što može 
imati negativan utjecaj na faktor rizika za razvoj kardiovaskularnih bolesti. U ovom radu je uspoređen utjecaj prehrane sa povećanim udjelom 
mononezasićenih masnih kiselina (maslinovo ulje) i prehrane sa povećanim udjelom polinezasićenih masnih kiselina (bučino ulje) na faktor 
rizika za razvoj kardiovaskularnih bolesti. Prehrana sa povećanim udjelom mononezasićenih masnih kiselina snizila je aterogeni indeks za 60%, 
a prehrana sa povećanim udjelom polinezasićenih masnih kiselina za 40% u odnosu na kontrolnu grupu, što je ujedno najznačajnija zabilježena 
razlika između ove dvije prehrane. Na osnovu rezultata prikazanih u ovom radu može se zaključiti da je dodatak oba ispitivana ulja u prehrani 
bolji nego prehrana bazirana na niskom sadržaju masnoća zbog povoljnijeg utjecaja na profi l lipida u krvi i faktore rizika za razvoj kardio-
vaskularnih bolesti.   
Ključne riječi: kolesterol, triacilglicerol, HDL i LDL kolesterol, maslinovo ulje, bučino ulje
of carbohydrates, these good fats decreased levels of harmful 
LDL and increase protective HDL (Mensink et al., 2003). Ran-
domized trial known as the Optimal Macronutrient Intake Trial 
for Heart Health (Omni Heart) showed that replacing a car-
bohydrate-rich diet with one rich in unsaturated fat, predomi-
nantly monounsaturated fats, lowers blood pressure, improves 
lipid levels, and reduces the estimated cardiovascular risk (Ap-
pel et al., 2005).  
MUFA- and PUFA-rich diets decrease the levels of total 
plasma cholesterol and LDL-cholesterol and increase serum 
HDL-cholesterol in healthy normolipidemic subjects (Grun-
dy, 1986; Grundy and Denke, 1990) and in mouse models of 
atherosclerosis (George et al., 2000).
Detailed description on lipid physiology and impact of di-
etary fats on lipid profi le has been given in review by Landeka 
et al. (2011). 
The aim of this study was to compare the impact of regu-
lar dietary intake of olive oil and pumpkin seed oil produced 
in Croatia on serum lipid profi le. Olive oil and pumpkin seed 
oil differ in PUFA and MUFA composition. Nutritional effects 
of olive oil on fat metabolism are well known and described 
(Acin et al., 2005; Kris-Etherton et al., 1999; Rocio et al., 
1999) while, on the other hand, pumpkin seed oil is less de-
scribed in literature. 
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Pumpkin seed oil is a regular component of meals in 
Northern Croatia (Delaš, 2009) whereas olive oil is a regularly 
used in Mediterranean part of Croatia. In recent years olive oil 
use increased but the results of these study show that pumpkin 
seed oil also may have benefi cial infl uence on lipid levels and 
profi le.
MATHERIALS AND METHODS
Animals and treatment  
Experiments were carried out according to the guidelines 
force in Croatia (Law on the Welfare of Animals, NN# 19, 
1999) and in compliance with the Guide for the Care and Use 
of Laboratory Animals, DHHS Publ. # (NIH) 86-123. Inbred 
Swiss mice 90±5 days, from the mouse colony of Faculty of 
Science, University of Zagreb were used. The animals were 
maintained on a formulated commercial pellet diet and water 
was provided ad libitum. The animals were maintained under 
12L:12D hour light-dark regime at 60% humidity.  Food pellets 
were a Standard mice and rat diet 4RF21 certifi cate (Mucedola, 
Italy; Batch No. 238603, shape 12 mm) composed of wheat, 
maize, soybean dehulled, corn gluten feed, wheat strow, fi sh 
meal, dicalcium phosphate, calcium carbonate, sodium chlo-
ride, whey powder, soybean oil, yeasts, hazelnut skins. Ana-
lytical components were 12% moisture, 18.50% protein, 3% 
fats, 6% crude fi bers, 7% crude ash, supplemented with E672 
(vitamin A), E671 (vitamin E), E1 (Fe), E5 (Mn), E6, (Zn), E4, 
(Cu), E2 (I), E3 (Co) added as sulphates or carbonates. 
Through the whole experiment on the days of treatment the 
body weight of the animals was recorded. Each group contained 
7 male animals. The fi rst group was a control group.  The control 
group was receiving physiological so-
lution (vehicle). The second group 
received olive oil. The third group 
was treated with pumpkin seed oil. 
All treated groups received by gauge 
a total volume of 0.2 ml/animal/day, 
repeatedly for 30 days. To avoid the 
false changes infl uenced by excessive 
blood loss caused by frequent sam-
pling the whole blood samples were 
collected on the 30th day of the exper-
iment respectively. On the 30th day 
the animals were anesthetized with 
izofourane (2% in a fl ow of oxygen) 
and exsangunated by intra-cardiac 
puncture without anticoagulant, as de-
scribed in EMPReSS, SOP (Standard 
Operating Procedure) (Green at al., 
2005). After coagulation the unhemo-
lysed serum was collected and frozen 
at -80°C until further processing that 
did not take more than fi ve days.  Con-
trol group data were within the normal 
reference ranges at the end of the ex-
periment and they were the reference 
point for comparison with the treated groups (Matsusawa et al., 
1998; James 1993).  The whole experiment was repeated twice 
and the statistical analysis showed no difference between the 
fi rst and the second experimental setup (repetition).
Biochemical analysis
Total triglyceride, cholesterol and high density lipoprotein 
(HDL) were measured using Hitachi 717 automatic analyzer 
(Hitachi, Japan) (Concensus Conference, 1985). The low den-
sity cholesterol (LDL) concentrations were calculated from the 
Friedewald equation: LDL-cholesterol: [LDL] = [C] - [HDL] 
- [TG/5], according to the manufacturer’s instructions (Fried-
wald at al., 1972).
Statistical  analysis
Statistical analyses were performed using Statistica 8.0 
software (Stat-Soft, Tulsa, USA). Each sample was character-
ized by the mean (± standard deviation of the mean). The unit 
of measurement was the animal. Multiple comparisons between 
control and treated groups were done by on log-transformed 
data in order to normalize the distribution and to equalize the 
variances. Level of statistical signifi cance was set at p ≤ 0.05. 
Post-hoc analysis of differences was conducted by Scheffé test 
to establish between the group differences (Zar, 1999).
RESULTS
There were no statistically signifi cant difference in weight 
gain between treated animals  and the control group (Figure 1). 
Over the course of experimental period none of the experimen-
tal animals had died nor did they show abnormal food intake or 
behavioral changes.   
Figure 1. The mean percentage of weight gain (± S.D.) from the beginning of the experiment in 
control animals, animals receiving olive oil (OO) and pumpkin seed oil (PSO). Between groups 
there were no statistically signifi cant differences.
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Effect of olive and 
pumpkin seed oil on serum 
triglycerides and cholesterol 
in mice fed for 30 d. In com-
parison to the control group 
are presented in Table 1. and 
Figure 2. The groups receiv-
ing olive oil had signifi cantly 
lower triglyceride levels in 
serum (10.90%) compared 
to control. Cholesterol levels 
were 5.78% lower than in 
control animals. HDL cho-
lesterol was 19.04% higher 
compared to control and LDL 
was 14.79% lower than in 
control animals. In the group 
receiving pumpkin seed oil 
diet cholesterol level was de-
creased for 2.68% compared 
to control and the triglyceride 
level in this group was sig-
nifi cantly lower (for 6.64%) 
than in the control group. 
HDL cholesterol level was signifi cantly higher for 16.70% 
compared to control group. LDL levels in serum signifi cantly 
descend (for 10.60%) compared to the controls. 
Both oils lowered the atherogenic index compared to the 
control. However, the most signifi cant difference between the 
two groups was that the atherogenic index in groups given ol-
ive oil was signifi cantly lower (for approximately 60%) than 
atherogenic index recorded in control group, while in the group 
receiving pumpkin seed oil this reduction was approximately 
40% of the atherogenic index recorded in control group. 
To assess how changes in plasma 
lipids correspond to changes in CVD 
risk status, we estimated the change in 
risk expected for the lipid and lipopro-
tein responses as follows: a 1% decrease 
in LDL cholesterol decreases CVD risk 
by 1.5% (Davis et al., 1990). The aver-
age 12.7% reduction in LDL cholesterol 
achieved with olive and pumpkin seed 
oil would be expected to decrease CVD 
risk by 19% (Figure 2).
DISCUSSION
A low-fat and low-cholesterol diet 
has been proposed as healthful eating 
for decades. It is assumed that there is 
a linear relationship between an over-
consumption of saturated fatty acids and 
atherogenesis, promoting CVD as a pri-
mary cause of mortality in industrialized 
countries. Recommendations in these 
countries are based on a collection of 
experimental, epidemiological, or nutri-
tional data published during the last 20 
years, showing that the CVD incidence is 
positively correlated with the total cholesterol (TC) concentra-
tion and negatively correlated with the high-density lipopro-
tein (HDL) threshold (Baudet et al., 1984; Esteva et al., 1986). 
Growing evidence shows that the structure of fatty acids and 
the number of double bonds between carbon atoms play a cen-
tral role in the etiology of numerous chronic diseases. Saturat-
ed fatty acid consumption increases the risk of coronary artery 
diseases, while unsaturated fatty acid consumption reduces this 
risk (Demaison and Moreau, 2002; Nagyova et al., 2003). Vari-
ous studies suggest a protective role of PUFA and MUFA, and 







HDL (mg/dl) 41.91±3.86a,b 49.89±3.97# 48.91±3.62#
1LDL (mg/dl) 94.18±3.78a,b 79.18±3.75# 84.19±3.44#
Cholesterol (mg/dl) 152.64±3.09 143.82±3.22 148.55±2.73 
Triglyceride (mg/dl) 82.74±5.06a,b 73.71±4.87# 77.25±5.1#
LDL/HDL 2.25±0.32a,b 1.59±0.29# 1.72±0.32#
Cholesterol/HDL 3.64±0.36 2.88±0.36 3.03±0.34 
2Atherogenic index 0.98±0.24a,b 0.37±0.22#,b 0.58±0.38#,a
Table 1. Effect of olive oil and pumpkin seed oil diet on mice serum lipid composition - after 30 days of diet.
1 LDL-cholesterol: [LDL] = [C] - [HDL] - [TG/5] 
2 Atherogenic index: [T] - [HDL] / [HDL] 
# - signifi cantly different from control
a - signifi cantly different from Olive oil
b - signifi cantly different from Pumpkin seed oil 
Figure 2. Effects of LDL-cholesterol, HDL-cholesterol, total cholesterol (C) and triacilglyc-
erol (TG) concentrations on cariovascular disease risk reduction in response to olive oil and 
pumpkin seed oil diets.
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a harmful effect of SFA in many other diseases affecting the ag-
ing population. This fi nding raises a question about ˝healthful 
eating˝ guidelines concerning fat and cholesterol in diet and, 
from a public health perspective, it is now time to reevaluate 
what the optimal diet is for lowering risk of CVD.
It is generally accepted that higher-fat diets that are high 
in MUFAs and low in SFAs lowers total and LDL cholesterol 
to a degree similar to that observed for a lower-fat, choles-
terol-lowering diet (Grundy, 1996; Grundy et al., 1988; Kris-
Etherton and Yu 1997; Mensink and Katan 1988). The Medi-
terranean diet, with its hallmark of high levels of utilization of 
olive oil (high in content with MUFA:PUFA=5:1), had a piv-
otal role in many studies. The Food and Drug Administration 
recommends using about 2 tablespoons (23 grams) of olive oil 
a day instead of other dietary fats to get its heart-healthy ben-
efi ts (Covas et al., 2006; Covas et al., 2008). Trichopoulou et 
al. (2005) suggested signifi cant reduction in mortality among 
patients with known coronary heart disease who adhered to a 
traditional Mediterranean diet. Fito et al. (2005) studied the ef-
fect of virgin olive oil, rich in phenolic compounds, and found 
that it signifi cantly decreased oxidized low-density lipoprotein 
(LDL) and lipid peroxide levels. Olive oil contains a potent 
mix of antioxidants that can lower “bad” (LDL) cholesterol but 
leave “good” (HDL) cholesterol untouched. 
Such results were confi rmed in this work with animals 
receiving olive oil. Animals receiving olive oil had 10.90% 
lower triglyceride levels in serum, 5.78% lower cholesterol 
levels and 14.79% lower LDL level compared to control. HDL 
cholesterol was even 19.04% higher compared to control.
For treatment group edible virgin olive oil (Zvijezda, 
Croatia) was used (ratio of unsat/sat = 4.8, 14% palmitic acid, 
2.8% stearic acid, 72.9% oleic acid, 8.6% linoleic acid) (Žanetić 
and Gugić, 2006) and pumpkin seed oil (Zvijezda, Croatia) 
was used (ratio of unsat/sat = 4.8, 11.2% palmitic acid, 5.2% 
stearic acid, 35% oleic acid, 47% linoleic acid) (Neđeral Nakić 
et al., 2006). 
Results of the present study provide further evidence that 
the oils rich in PUFA may have similar effect. This fi nding has 
not been typically reported. The major ω-6 fatty acid in the 
diet is linoleic acid, which serves as the precursor for arachi-
donic acid (20:4n-6), which has important biological effects in 
the body. Linoleic acid is not synthesized by the body and is 
therefore an essential fatty acid (Siguel et al., 1987). Pumpkin 
seed oil is rich in linoleic acid. Linoleic acid clearly has a hy-
pocholesterolemic effect when substituted for dietary saturated 
fatty acids, reducing LDL cholesterol concentrations as well. 
Pumpkin seed oil is a natural product commonly used in folk 
medicine. It was shown in several countries that the incidence 
of hypertension, atherosclerosis and prostatic hypertrophy was 
reduced in people regularly consuming the seed (Harvath and 
Bedo, 1988). Such effects were demonstrated in this work with 
animals receiving pumpkin seed oil. Cholesterol level in this 
group of animals was decreased for 2.68% compared to con-
trol, the triglyceride level was 6.64% lower and LDL level in 
serum was descended for 10.60% compared to the controls. On 
the other hand HDL cholesterol level was signifi cantly higher 
(for 16.70%) compared to control group. Such results might be 
a consequence of rich linoleic acid content of pumpkin seed 
oil. This fi ndings show that food source rich in PUFAs (i.e. 
pumpkin seed oil) could also be used in designing diets for 
reduction of CVD risk. 
An important fi nding reported in the present study is that a 
high-MUFA and a high-PUFA diet gave 40 to 60% reduction of 
atherogenic index in mice compared with an average diet. The 
average 12.7% reduction in LDL cholesterol achieved with ol-
ive and pumpkin seed oil would be expected to decrease CVD 
risk by 19%.
On the basis of the results of the present study, it appears 
that a high-MUFA, cholesterol-lowering diet is superior to a 
low-fat diet such as the Step II diet. Although the reduction in 
CVD risk due to a decrease in LDL cholesterol is similar for a 
high-MUFA diet and a low-fat diet (Step II diet), a high-MUFA 
diet lowers triacylglycerol and does not decrease HDL choles-
terol. In contrast, a Step II diet increases triacylglycerol and 
lowers HDL cholesterol, thereby possibly undone some of the 
benefi cial effects of reducing LDL cholesterol.
CONCLUSIONS
Both high-MUFA and high-PUFA diets showed decrease 
in cholesterol, triglyceride and LDL level, and on the other 
hand increase in HDL level in serum of treated animals com-
pared to the controls. High-MUFA and a high-PUFA diet gave 
40 - 60% reduction of atherogenic index in mice compared 
with an average diet. The average 12.7% reduction in LDL 
cholesterol achieved with olive and pumpkin seed oil would 
be expected to decrease CVD risk by 19%. According to this 
results high-MUFA and high-PUFA, cholesterol-lowering diet 
may be preferable to a low-fat diet because of more favorable 
effects on the CVD risk profi le.
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Selected Abbreviations and Acronyms:
MUFA - monounsaturated fatty acid
PUFA - polyunsaturated fatty acid
SFA - saturated fatty acid
TG – total triglyceride
C – total cholesterol
VLDL – very low density lipoprotein
HDL – high density lipoprotein
LDL – low density lipoprotein
CHD – coronary heart disease 
CVD - cardiovascular disease 
SOP – Standard Operating Procedure
C – control
OO – Olive oil
PSO – Pumpkin seed oil
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